Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony C Gordon

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
Trials|August 25, 2020
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trialsJonathan A C Sterne, Janet Diaz, Jesús Villar, et al.
BMJ Open|December 10, 2023
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UKTimothy Simon Walsh, Leanne M Aitken, Cathrine A McKenzie, et al.
The Lancet. Respiratory Medicine|March 26, 2026
Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort studyKiran Reddy, Pratik Sinha, David B Antcliffe, et al.
BMJ Open|March 26, 2026
SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsisPhil Mawson, Miranda Morton, Zoe Walmsley, et al.
The Journal of Infectious Diseases|May 25, 2021
Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 InfectionJeremy Ratcliff, Dung Nguyen, Matthew Fish, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2008
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsisMark M Wurfel, Anthony C Gordon, Tarah D Holden, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluationTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Journal of Clinical Microbiology|March 24, 2022
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCRJeremy Ratcliff, Farah Al-Beidh, Sagida Bibi, et al.
Science Translational Medicine|June 5, 2024
High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient responseYuxin Mi, Katie L Burnham, Philip D Charles, et al.
JAMA|May 19, 2025
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical TrialTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Trials|August 25, 2020
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trialsJonathan A C Sterne, Janet Diaz, Jesús Villar, et al.
BMJ Open|December 10, 2023
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UKTimothy Simon Walsh, Leanne M Aitken, Cathrine A McKenzie, et al.
The Lancet. Respiratory Medicine|March 26, 2026
Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort studyKiran Reddy, Pratik Sinha, David B Antcliffe, et al.
BMJ Open|March 26, 2026
SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsisPhil Mawson, Miranda Morton, Zoe Walmsley, et al.
The Journal of Infectious Diseases|May 25, 2021
Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 InfectionJeremy Ratcliff, Dung Nguyen, Matthew Fish, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2008
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsisMark M Wurfel, Anthony C Gordon, Tarah D Holden, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluationTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Journal of Clinical Microbiology|March 24, 2022
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCRJeremy Ratcliff, Farah Al-Beidh, Sagida Bibi, et al.
Science Translational Medicine|June 5, 2024
High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient responseYuxin Mi, Katie L Burnham, Philip D Charles, et al.
JAMA|May 19, 2025
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical TrialTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Pageof 16